FDA approves two drugs, companion diagnostic test for melanoma
Tafinlar and Mekinist from GlaxoSmithKline, and the THxID BRAF Kit by bioMérieux of Grenoble, France are approved to treat and test for advanced skin cancer
2013-05-31 U.S. Food and Drug Administratio

Login/Register
Supplier Login












Home










